Novogene, headquartered in Beijing with branches in Hong Kong, the U.S. and U.K., is a leading genomics solution provider with cutting edge bioinformatics expertise and the largest Illumina-based sequencing capacity in China. Committed to quality service and scientific excellence, Novogene has achieved rapid growth and industry recognition by working in partnership with diverse healthcare, educational and research institutions around the globe to realize the unlimited potential of the rapidly evolving world of genomics. The company has completed nearly 10,000 major service projects with over 180 publications in top-ranked journals such as Science and Nature series. Novogene is the first company in China to purchase Illumina’s HiSeq X Ten System and is the only Illumina Genome Network partner in China. After achieving tremendous success in China, the company is expanding globally and established Novogene Corporation in the U.S. and Novogene Company Limited in the U.K. in 2014 to better serve global customers.